Alexion Complement Foundation is categorized under Organizations in Cheshire, CT and active since 2011.
Alexion Complement Foundation was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Organizations business, which does work in the BOTH market, and is classified as a Organizations, under code number 813410 by the NAICS.
If you are seeking more information, feel free to contact Leonard Bell at the company’s single location by writing to 352 Knotter Drive, Cheshire, Connecticut CT 06410 or by phoning (203) 271-8367. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alexion Complement Foundation |
| Contact Person: | Leonard Bell |
| Address: | 352 Knotter Drive, Cheshire, Connecticut 06410 |
| Phone Number: | (203) 271-8367 |
| Website Address: | alexionpharm.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Organizations |
| SIC Code: | 8699 |
| NAICS Code: | 813410 |
| Share This Business: |
Alexion Complement Foundation was started in 2011 to provide professional Organizations under the SIC code 8699 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Leonard Bell for inquiries that concern Alexion Complement Foundation by calling the company number (203) 271-8367, as your correspondence is most welcome. Additionally, the physical location of the single location of Alexion Complement Foundation can be found at the coordinates 41.549635,-72.924438 as well as the street address 352 Knotter Drive in Cheshire, Connecticut 06410.
For its online presence, you may visit Alexion Complement Foundation’s website at alexionpharm.com and engage with its social media outlets through on Twitter and on Facebook.